0001437749-15-016546.txt : 20150827
0001437749-15-016546.hdr.sgml : 20150827
20150827190908
ACCESSION NUMBER: 0001437749-15-016546
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150825
FILED AS OF DATE: 20150827
DATE AS OF CHANGE: 20150827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPAX LABORATORIES INC
CENTRAL INDEX KEY: 0001003642
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 650403311
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
BUSINESS PHONE: 510-240-6000
MAIL ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARKBREITER MICHAEL
CENTRAL INDEX KEY: 0001025714
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34263
FILM NUMBER: 151079791
MAIL ADDRESS:
STREET 1: BATTLE FOWLER LLP
STREET 2: 75 EAST 55TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
rdgdoc.xml
FORM 4
X0306
4
2015-08-25
0001003642
IMPAX LABORATORIES INC
IPXL
0001025714
MARKBREITER MICHAEL
C/O IMPAX LABORATORIES, INC.
30831 HUNTWOOD AVENUE
HAYWARD
CA
94544
1
Common Stock
2015-08-25
4
S
0
9399
41.67
D
8200
D
Common Stock
2015-08-26
4
M
0
10000
6.55
A
18200
D
Common Stock
2015-08-26
4
S
0
10000
42.78
D
8200
D
Stock Option (Right to Buy)
6.55
2015-08-26
4
M
0
10000
0
D
2019-05-20
Common Stock
10000
0
D
The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $40.88 to $42.64 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $41.65 to $43.46 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
100% of the shares subject to the option are fully vested and exercisable.
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Mark A. Schlossberg, by Power of Attorney
2015-08-27